Living Platform,Ltd. (JPX: 7091.T) AI-Powered Stock Analysis
See how Living Platform,Ltd. scores across key metrics like financial growth, valuation, and market position on the JPX, using AI-driven evaluation.
7091.T●JPX
HealthcareMedical - Care Facilities
¥1211.00
¥25.00(2.11%)
Japanese Market is Open · 14:09
Living Platform,Ltd. (JPX: 7091.T) AI-Powered Stock Analysis
See how Living Platform,Ltd. scores across key metrics like financial growth, valuation, and market position on the JPX, using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerLiving Platform,Ltd. (JPX: 7091.T) Stock Overall Grade
Living Platform,Ltd.'s grade for its JPX listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Living Platform,Ltd.'s overall JPX stock rating.
Forecast
A+Score
91/100Financial Growth
CScore
40/100Fundamental Growth
C+Score
56/100Key Ratios
BScore
69/100Sector Comparison
BScore
65/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
97/100Analyst Consensus
C+Score
50/100Living Platform,Ltd. (JPX: 7091.T) AI-Powered Stock Analysis
On the JPX, 7091.T demonstrates Good performance with an overall Forecast Score of 91/100 (A+), reflecting high confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (56/100, C+) highlight its stability, while Key Ratios (69/100, B) and Sector Comparison (65/100, B) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (97/100, A+), the JPX-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests Moderate divergence in outlook.(JPX: 7091.T) Component Analysis Explained
Understand the key factors behind each Living Platform,Ltd. (JPX: 7091.T) stock grade, including financials, comparisons, and forecasts.